M1 macrophages - unexpected contribution to tumor progression.

Area of Science:

• Immunology
• Oncology
• Cancer Biology

Background:

• The immune system, particularly interferon-γ-activated cells, plays a crucial role in anti-tumor immunity.
• Tumor immunoediting describes the dynamic interaction between the immune system and cancer cells, influencing tumor evolution.
• Macrophages, natural killer cells, and T lymphocytes are key players in anti-tumor responses, with M1 macrophages traditionally linked to tumor eradication and M2 macrophages to immune suppression.

Purpose of the Study:

• To examine the complex, context-dependent functions of M1 macrophages in anti-tumor immunity.
• To reassess current therapeutic strategies focused on enhancing M1 macrophage cytotoxicity.
• To propose a paradigm shift in immunotherapy design considering macrophage plasticity and tumor dynamics.

Main Methods:

• Review of existing literature on macrophage polarization and function in cancer.
• Analysis of the tumor immunoediting process and immune pressure.
• Examination of the paradoxical role of M1 macrophages in tumor progression.

Main Results:

• M1 macrophages, initially cytotoxic, can inadvertently promote tumor progression.
• Sustained cytotoxic pressure from M1 macrophages selects for more malignant and immune-resistant tumor clones.
• Current strategies enhancing M1 cytotoxicity may risk accelerating tumor evolution and immune evasion.

Conclusions:

• A binary view of M1 and M2 macrophages is insufficient; their roles are context-dependent.
• Therapeutic strategies should move beyond solely promoting M1 polarization.
• A nuanced understanding of macrophage plasticity and tumor dynamics is essential for developing effective immunotherapies that avoid unintended support of tumor evolution.